NO20054172D0 - Nye blandinger - Google Patents
Nye blandingerInfo
- Publication number
- NO20054172D0 NO20054172D0 NO20054172A NO20054172A NO20054172D0 NO 20054172 D0 NO20054172 D0 NO 20054172D0 NO 20054172 A NO20054172 A NO 20054172A NO 20054172 A NO20054172 A NO 20054172A NO 20054172 D0 NO20054172 D0 NO 20054172D0
- Authority
- NO
- Norway
- Prior art keywords
- new mixtures
- mixtures
- new
- Prior art date
Links
- 239000000203 mixture Substances 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/08—Solutions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A61K9/006—Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A61K31/4468—Non condensed piperidines, e.g. piperocaine having a nitrogen directly attached in position 4, e.g. clebopride, fentanyl
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/12—Aerosols; Foams
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P23/00—Anaesthetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Dispersion Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Neurology (AREA)
- Engineering & Computer Science (AREA)
- Nutrition Science (AREA)
- Physiology (AREA)
- Anesthesiology (AREA)
- Pain & Pain Management (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB0305579.5A GB0305579D0 (en) | 2003-03-11 | 2003-03-11 | Pharmaceutical compositions |
GB0328023A GB2399286A (en) | 2003-03-11 | 2003-12-03 | Sub-lingual fentanyl formulation |
PCT/GB2004/001037 WO2004080382A2 (en) | 2003-03-11 | 2004-03-11 | Novel compositions containing fentanyl |
Publications (2)
Publication Number | Publication Date |
---|---|
NO20054172D0 true NO20054172D0 (no) | 2005-09-07 |
NO20054172L NO20054172L (no) | 2005-10-06 |
Family
ID=32992592
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO20054172A NO20054172L (no) | 2003-03-11 | 2005-09-07 | Nye blandinger |
Country Status (10)
Country | Link |
---|---|
EP (1) | EP1608372A2 (no) |
JP (1) | JP2006519770A (no) |
KR (1) | KR20050115276A (no) |
AU (1) | AU2004218876B2 (no) |
BR (1) | BRPI0408209A (no) |
CA (1) | CA2516338A1 (no) |
MX (1) | MXPA05009602A (no) |
NO (1) | NO20054172L (no) |
NZ (1) | NZ541781A (no) |
WO (1) | WO2004080382A2 (no) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2597956C (en) | 2005-02-17 | 2013-07-09 | Velcera Pharmaceuticals | Transmucosal administration of drug compositions for treating and preventing disorders in animals |
GB0514043D0 (en) * | 2005-07-08 | 2005-08-17 | Arakis Ltd | Fentanyl formulation |
SI1976521T1 (sl) | 2006-01-25 | 2015-06-30 | Insys Therapeutics, Inc. | Podjezično fentanilno pršilo |
WO2009017837A2 (en) | 2007-08-02 | 2009-02-05 | Insys Therapeutics Inc. | Sublingual fentanyl spray |
GB2476494A (en) * | 2009-12-24 | 2011-06-29 | Norwich Pharma Technologies Ltd | Formulation for the sublingual delivery of sufentanil |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE19536244A1 (de) * | 1994-09-30 | 1996-04-04 | Juergen Dr Regenold | Pharmazeutische Zusammensetzung zur lokalen Applikation |
DE69738333T2 (de) * | 1997-10-01 | 2008-11-27 | Novadel Pharma Inc. | Nichtpolares Spray zur bukkalen Verabreichung |
US20030185761A1 (en) * | 1997-10-01 | 2003-10-02 | Dugger Harry A. | Buccal, polar and non-polar spray or capsule containing drugs for treating pain |
SE9803239D0 (sv) * | 1998-09-24 | 1998-09-24 | Diabact Ab | Composition for the treatment of acute pain |
US6849263B2 (en) * | 1998-12-21 | 2005-02-01 | Generex Pharmaceutical Incorporated | Pharmaceutical compositions for buccal delivery of pain relief medications |
AU2879100A (en) * | 1999-02-12 | 2000-08-29 | Miles A. Libbey Iii | Formulation and system for intra-oral delivery of pharmaceutical agents |
AU2001262992A1 (en) * | 2000-05-10 | 2002-02-18 | University Of Kentucky Research Foundation | System and method for intranasal administration of opioids |
DE10064219B9 (de) * | 2000-12-22 | 2009-02-12 | Nasalis Pain Relief International Gmbh | Neue Fentanyl und/oder dessen Derivate enthaltende pharmazeutische Zusammensetzung zur nasalen Anwendung |
-
2004
- 2004-03-11 KR KR1020057016853A patent/KR20050115276A/ko not_active Ceased
- 2004-03-11 BR BRPI0408209-5A patent/BRPI0408209A/pt not_active IP Right Cessation
- 2004-03-11 MX MXPA05009602A patent/MXPA05009602A/es not_active Application Discontinuation
- 2004-03-11 AU AU2004218876A patent/AU2004218876B2/en not_active Ceased
- 2004-03-11 WO PCT/GB2004/001037 patent/WO2004080382A2/en active IP Right Grant
- 2004-03-11 CA CA002516338A patent/CA2516338A1/en not_active Abandoned
- 2004-03-11 NZ NZ541781A patent/NZ541781A/en unknown
- 2004-03-11 JP JP2006500257A patent/JP2006519770A/ja active Pending
- 2004-03-11 EP EP04719527A patent/EP1608372A2/en not_active Withdrawn
-
2005
- 2005-09-07 NO NO20054172A patent/NO20054172L/no not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
NO20054172L (no) | 2005-10-06 |
CA2516338A1 (en) | 2004-09-23 |
JP2006519770A (ja) | 2006-08-31 |
WO2004080382A3 (en) | 2005-03-24 |
BRPI0408209A (pt) | 2006-02-14 |
NZ541781A (en) | 2008-04-30 |
WO2004080382A2 (en) | 2004-09-23 |
EP1608372A2 (en) | 2005-12-28 |
AU2004218876B2 (en) | 2007-08-02 |
KR20050115276A (ko) | 2005-12-07 |
MXPA05009602A (es) | 2005-11-08 |
AU2004218876A1 (en) | 2004-09-23 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO20054224D0 (no) | Nye 2-pyridinkarboksamidderivater | |
NO20055219D0 (no) | Nye forbindelser | |
NO20054005D0 (no) | Nye arylpiperazinylforbindelser | |
FI20030583A0 (fi) | Dataprojektori | |
NO20044588L (no) | Nye forbindelser | |
NO20044432L (no) | Nye forbindelser | |
IS8228A (is) | Ný asetídínefnasambönd | |
IS8440A (is) | Múskarínasetýlkólínviðtakamótlyf | |
IS8292A (is) | Ný efnasambönd | |
DK1704148T3 (da) | Nye kondenserede pyrrolocarbazoler | |
DE10355350A8 (de) | Elektromodul | |
NO20055750D0 (no) | Nye kjemiske forbindelser | |
ATE444953T1 (de) | Substituierte spirobenzazepine | |
NO20044098L (no) | Nye forbindelser | |
NO20054172D0 (no) | Nye blandinger | |
DE50305802D1 (de) | Stanz-prägeniet | |
DE502004006563D1 (de) | Brieftaubenkonstatiersystem | |
DE502004005162D1 (de) | Leistungsregelvorricthung | |
SE0303452D0 (sv) | New compounds | |
DE10329218B4 (de) | Hotflue | |
DE502004007251D1 (de) | En 2-arylpropenalen | |
NO20055846D0 (no) | Nye IL-8-liknende polypeptider | |
DE502004001283D1 (de) | Umsymmetrieranordnung | |
NO20050026L (no) | Nye benzodioksoler | |
IS8444A (is) | Staðgengin indól-o-glúkósíð |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FC2A | Withdrawal, rejection or dismissal of laid open patent application |